Tower Research Capital (TRC)’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2K | Buy |
12,779
+2,645
| +26% | +$7.09K | ﹤0.01% | 3302 |
|
|
2025
Q1 | $14.3K | Buy |
10,134
+4,537
| +81% | +$6.4K | ﹤0.01% | 3304 |
|
|
2024
Q4 | $11.1K | Buy |
5,597
+951
| +20% | +$1.89K | ﹤0.01% | 3746 |
|
|
2024
Q3 | $14.6K | Buy |
+4,646
| New | +$14.6K | ﹤0.01% | 3448 |
|
|
2024
Q1 | – | Sell |
-14,641
| Closed | -$24.3K | – | 5830 |
|
|
2023
Q4 | $24.3K | Buy |
14,641
+10,521
| +255% | +$17.5K | ﹤0.01% | 3536 |
|
|
2023
Q3 | $3.7K | Sell |
4,120
-1,601
| -28% | -$1.44K | ﹤0.01% | 4969 |
|
|
2023
Q2 | $12.3K | Buy |
5,721
+5,658
| +8,981% | +$12.2K | ﹤0.01% | 3863 |
|
|
2023
Q1 | $0 | Sell |
63
-2,872
| -98% | – | ﹤0.01% | 5752 |
|
|
2022
Q4 | $11K | Sell |
2,935
-6,538
| -69% | -$24.5K | ﹤0.01% | 3785 |
|
|
2022
Q3 | $46K | Buy |
9,473
+8,773
| +1,253% | +$42.6K | ﹤0.01% | 3227 |
|
|
2022
Q2 | $6K | Sell |
700
-37
| -5% | -$317 | ﹤0.01% | 4887 |
|
|
2022
Q1 | $10K | Sell |
737
-1,452
| -66% | -$19.7K | ﹤0.01% | 4268 |
|
|
2021
Q4 | $44K | Buy |
2,189
+2,144
| +4,764% | +$43.1K | ﹤0.01% | 2853 |
|
|
2021
Q3 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 5416 |
|
|
2021
Q2 | – | Sell |
-82
| Closed | -$2K | – | 5425 |
|
|
2021
Q1 | $2K | Sell |
82
-4,521
| -98% | -$110K | ﹤0.01% | 4993 |
|
|
2020
Q4 | $147K | Buy |
+4,603
| New | +$147K | ﹤0.01% | 1998 |
|